NCT05695664

Brief Summary

Objectives: To compare the postoperative analgesic effects of ibuprofen versus ketorolac in patients undergoing orthopedic surgery at Combined Military Hospital, Rawalpindi. Study design: Randomized controlled trial Setting: Department of Anasthesiology, Combined military Hospital, Rawalpindi Duration of study:6 months (01st August 2021 to 31st January 2022) Material and methods: After ethical approval, 100 patients in randomly divided two equal groups (A and B) were selected. In group A, 800 mg IV ibuprofen while in group B, 30 mg IV ketorolac was given within 30 min of skin closure after orthopedic surgery. The pain was assessed via visual analogue scale postoperatively. The SPSS version 25 was used for analysis of data. P value ≤ 0.05 was considered as significant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Aug 2021

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 25, 2023

Completed
Last Updated

January 25, 2023

Status Verified

January 1, 2023

Enrollment Period

6 months

First QC Date

January 12, 2023

Last Update Submit

January 20, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain

    Postoperative pain measured by visual analogue scale (VAS), in which 0 is no pain and 10 is the maximum possible bearable pain.

    3, 6 and 12 hours in postoperative period

  • Rescue analgesia requirement

    Inj. Ketorolac 30 mg as Rescue analgesic was used intravenouly when VAS was equal or more than 4

    12 hours in the postoperative period

Study Arms (2)

Ibuprofen

EXPERIMENTAL

patient received 800 mg of Ibuprofen IV

Drug: Ibuprofen 800 mg

Ketorolac

EXPERIMENTAL

Patients received Keterolac 30 mg IV

Drug: Ketorolac Injection

Interventions

Intravenous injection of ibuprofen 800 mg

Ibuprofen

Intravenous injection of Ketorolac 30 mg

Ketorolac

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of either gender undergo orthopedic surgery were included in the study.
  • ASA ≤ 2
  • Age 40-80 years.
  • Fracture Radius , Ulna, and wrist

You may not qualify if:

  • Patients with history of adverse response from ketorolac and ibuprofen was not taken into the study.
  • Patients with history of epilepsy.
  • Patients with history of cardiac conduction defects.
  • Patients on antiarrhythmic drugs or analgesics.
  • Patients with H/O stroke, renal impairment, chronic obstructive pulmonary disease, asthma, chronic liver disease, hypothyroidism and CCF were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fazal Hussain

Bhakkar, Punjab Province, 300000, Pakistan

Location

Related Publications (5)

  • Greimel F, Maderbacher G, Zeman F, Grifka J, Meissner W, Benditz A. No Clinical Difference Comparing General, Regional, and Combination Anesthesia in Hip Arthroplasty: A Multicenter Cohort-Study Regarding Perioperative Pain Management and Patient Satisfaction. J Arthroplasty. 2017 Nov;32(11):3429-3433. doi: 10.1016/j.arth.2017.05.038. Epub 2017 May 26.

    PMID: 28641966BACKGROUND
  • Hernandez-Boussard T, Graham LA, Desai K, Wahl TS, Aucoin E, Richman JS, Morris MS, Itani KM, Telford GL, Hawn MT. The Fifth Vital Sign: Postoperative Pain Predicts 30-day Readmissions and Subsequent Emergency Department Visits. Ann Surg. 2017 Sep;266(3):516-524. doi: 10.1097/SLA.0000000000002372.

    PMID: 28657940BACKGROUND
  • Masala IF, Caso F, Sarzi-Puttini P, Salaffi F, Atzeni F. Acute and chronic pain in orthopaedic and rheumatologic diseases: mechanisms and characteristics. Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 105(3):127-131. Epub 2017 Jun 29.

    PMID: 28681710BACKGROUND
  • Lavie LG, Fox MP, Dasa V. Overview of Total Knee Arthroplasty and Modern Pain Control Strategies. Curr Pain Headache Rep. 2016 Nov;20(11):59. doi: 10.1007/s11916-016-0592-6.

    PMID: 27655139BACKGROUND
  • Ramia E, Nasser SC, Salameh P, Saad AH. Patient Perception of Acute Pain Management: Data from Three Tertiary Care Hospitals. Pain Res Manag. 2017;2017:7459360. doi: 10.1155/2017/7459360. Epub 2017 Mar 28.

    PMID: 28458592BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

IbuprofenKetorolac

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsIndomethacinIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant General Surgeon

Study Record Dates

First Submitted

January 12, 2023

First Posted

January 25, 2023

Study Start

August 1, 2021

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

January 25, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations